Vivus Inc. will be required to conduct 10 postmarketing requirements, including a long-term cardiovascular outcomes trial to assess the effect of Qsymia on the risk for major adverse cardiac events such as heart attack and stroke.Good Luck.
What do you think the stock price will open up with tomorrow? what it closed at today 26.14 and then go up? or start much higher.. i'm not sure how that works so that's why i'm asking.. does it start at where it ended off or can it start like at 30.00 cuz of the news tonight? can someone explain that to me?
I agree..the person that is saying what Vivus is requiring to do and wishing us Good Luck is the same person that posted that the drug is not going to be approved and had several people believe it was a vivus employee cash out on vivus stock.. What a horrible thing to do...if this person was in front of me right now..or anyone of these other people..i'm telling you..i can't say what i want to say on here.. i'm no kidding either.. kharma baby kharma..
